Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,786.50
Bid: 1,786.00
Ask: 1,786.50
Change: 8.50 (0.48%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,787.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Ends April In The Black

Wed, 30th Apr 2014 16:29

LONDON (Alliance News) - The FTSE 100 closed marginally higher Wednesday, adding to gains posted on Monday and Tuesday, and ensuring that the blue-chip index closed the month of April firmly higher than it opened it.

Meanwhile, it was a volatile day in the forex market following a raft of top-tier macro economic releases from the US and Europe.

The FTSE 100, which spent the day trading in a tight range as investors await the outcome of the latest Federal Open Market Committee meeting after the UK equity market close, was partly lifted by a strong performance by Royal Dutch Shell.

The oil giant, which is the largest company in the FTSE 100 by market capitalisation, closed up 2.9% after it said its earnings almost halved in the first quarter of the year, as it wrote down some of the value of its refineries in Europe and Asia due to declining refining margins and as its production fell.

However, it also said it would pay a higher dividend for the quarter as it returns some of the funds from its asset-sale programme to its shareholders.

Overall, UK stocks closed mixed. The FTSE 100 closed up 0.5% at 6,780.03, meaning it added 2.8% in the month of April. The FTSE 250 closed down 0.5% Wednesday, and down 2.8% for the month, while the AIM All-Share index closed up 0.9% Wednesday, but down 3.3% for the month.

It was a similar story in Europe, where the CAC 40 in Paris closed down 0.2% Wednesday and the DAX 30 closed up 0.2%.

Within the UK FTSE 350 sector indices, the oil and gas producer sector was the best performing sector, closing up 1.7%, as shares in FTSE 100-listed Tullow Oil and FTSE 250-constituent Heritage Oil also rose sharply.

Tullow ended the day up 1.7% after it sold stakes in two assets to AIM-listed Faroe Petroleum for USD75.6 million plus a royalty on developments at one of the assets.

The company, which also said its 2014 production guidance remains unchanged at between 79,000 and 85,000 barrels of oil equivalent a day, said that Faroe is buying 60% of its Ketch asset and 53.1% of the Schooner asset in which Tullow holds 93.1%. Tullow said it will pay USD58.8 million when the deal completes and the rest when cumulative production milestones are hit.

Meanwhile, Heritage Oil jumped 23% after it said it had recommended a GBP924 million takeover offer from Al Mirqab Capital, an investment vehicle controlled by the royal family of Qatar. It said Al Mirqab had offered 320 pence per share in cash for the company, a deal that it is recommending and that is supported by the independent directors on its board. Heritage Oil's shares closed up 22.4% at 312.7947 pence Wednesday.

Away from the oil and gas production companies, Rolls-Royce Holdings was amongst the biggest risers in the blue-chip index. The company's shares rose after it said late on Tuesday that it is in talks with Germany's Siemens AG about a possible sale of its energy gas turbine and compressor business.

Playtech was among the biggest risers in the FTSE 250, closing up 4.5%. Shares in the online gaming software supplier rose after it expressed confidence in its continuing growth prospects for 2014, as it reported a rise in revenue in the quarter to end-March.

The group posted revenue of EUR102.7 million in the quarter, up from EUR87.5 million a year before, driven by strong performances in its Casino, Services and Sport divisions. It said that average daily revenue for the first 29 days of its second quarter are up over 15% compared to the previous year.

At the other end of the spectrum, CSR was the mid-cap index's heaviest faller, ending the day down 10%. The chip maker swung to a pretax loss in the first quarter to March 28, hit by the continued decline of its legacy products.

The company posted a pretax loss of USD4.0 million, versus a profit of USD1.1 million a year before, as revenue declined to USD180.8 million from USD237.9 million in the previous year. The decline in revenue was primarily caused by what the chip maker calls its legacy products, which declined 57%, as the products reached the end of their life cycle.

GlaxoSmithKline, closing down 2%, was a big faller in the FTSE 100. The drugs giant reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite making its sales guidance more vague.

British American Tobacco was another heavy loser, falling 2%. The world's second-largest listed tobacco company by revenue after Philip Morris International Inc said that revenue grew slightly at constant exchange rates in the first quarter, but dropped significantly when taking into account currency movements in the quarter.

The group said that group revenue for the three months to end of March, at current exchange rates, declined by 12%, hit by the current strength of sterling against some of BAT's key revenue-generating currencies, notably the Brazilian real, South African rand, Japanese yen and Australian dollar. The group also reiterated that while emerging market volumes are increasing, the trading environment in Western Europe remains challenging.

However, it was Tesco, which ended the day down 3.1%, that was the biggest loser in the blue-chip index Wednesday, after it went ex-dividend, meaning new buyers no longer qualify for the latest dividend payout. Similarly, William Hill closed down 2.7%, Admiral Group closed down 3.1% and Weir Group closed down 1.4% after going ex-dividend.

In the FTSE 250, SIG, which closed down 3.8%, Hunting, which closed down 4%, and Spirax-Sarco Engineering, which closed down 1.3%, also went ex-dividend Wednesday.

In the forex market, the euro jumped against the pound and the dollar in early trading.

The single currency rose sharply, after initially plummeting, in the wake of the release of the latest consumer price inflation data for the eurozone.

The preliminary reading of April's year-on-year CPI for the single currency area accelerated from a four-year low, coming in at 0.7% from 0.5% in March. Although this meant inflation edged up from its 2009 lows, it fell short of the 0.8% that economists had been expecting.

"The ship is starting to sink and time is running out for the European Central Bank to divert a 1990s Japanese-style bout of deflation," said Dennis de Jong, managing director at UFXMarkets.

"Inflation simply isn’t rising quick enough and stimulus is required, be it through the introduction of quantitative easing or negative interest rates. (ECB President) Mario Draghi has said that he is prepared to take emergency measures, but now is the time for action rather than words," de Jong Warns.

UBS economist Gyorgy Kovacs is less concerned. "While headline inflation is still uncomfortably low, the data still don't signal any trend towards deflation," he says. For one, core inflation rebounded to 1.0% year-on-year, "which means that core inflation has not exhibited any clear downtrend since April, 2013."

Later in the day, the dollar dropped significantly against its major rivals following the release of some highly anticipated US data.

The fall came after the preliminary reading of US gross domestic product revealed that the world's largest economy grew less than forecast in the first quarter, driven by the impact of severe winter weather.

The US Commerce Department said gross domestic product inched up by just 0.1% in the first quarter of 2014 compared to the 2.6% increase in GDP in the fourth quarter of 2013. While economists had anticipated a notable slowdown in the pace of GDP growth, they still expected an increase of about 1.2%.

"The biggest shocker for some time, is how I would describe the US GDP miss for the first quarter," said Kathleen Brooks, research director at Forex.com.

A strong ADP employment report released just a few minutes before the disappointing growth data was not enough to lift the dollar. The report showed that private sector employment in the US continued to grow significantly in the month of April. ADP said private sector employment surged up by 220,000 jobs in April following an upwardly revised jump of 209,000 jobs in March.

At the close of the UK equity market, the euro trades at USD1.3868, while the pound trades at EUR1.2170 and USD1.6884.

The much weaker-than-expected US GDP report comes before Federal Open Market Committee interest rate and monetary policy decisions at 1800 GMT.

Expectations are for the FOMC to keep its interest rates unchanged at 0.25% and to taper its monthly asset purchases by another USD10 billion.

However, there is now an "increased risk that the Fed could hold pat on asset purchases for this month," says Brooks. While she believes that this is an unlikely outcome, if the Fed sounds concerned about growth, "and then does not taper asset purchases, the market reaction could be severe," she warns.

In the data calendar Thursday, UK Nationwide housing price figures for March are released at 0600 GMT, ahead of the latest Markit manufacturing purchasing managers' index, consumer credit, and mortgage approvals data at 0830 GMT.

In the US, Federal Reserve Chair Janet Yellen gives a speech at 1230 GMT. Weekly jobless claims data are released at the same time, along side personal consumption and income information. Markit manufacturing PMI is released at 1345 GMT, ahead of the ISM manufacturing PMI at 1400 GMT.

In the corporate calendar, FTSE 100-listed BG Group, British Sky Broadcasting, Smith & Nephew, and Shire are joined by FTSE 250-listed Millennium & Copthorne Hotels and Lancashire Holdings in releasing quarterly results. Blue-chips Lloyds Banking Group, Weir Group, Schroders, and Roll-Royce Holdings, and mid-caps RPS Group, Phoenix Group Holdings, Synthomer, Go-Ahead Group, and Howden Joinery Group provide trading updates.

FTSE 250-constituent N Brown Group publishes full-year results.


By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.